You just read:

Merrimack Unveils its Latest Antibody Directed Nanotherapeutic, MM-310, at the 2016 AACR Annual Meeting

News provided by

Merrimack Pharmaceuticals, Inc.

21 Apr, 2016, 08:00 ET